Author

Amy K. Harker-Murray

Observed name: Amy Harker-Murray

Institution: Medical College of Wisconsin

Observed institutions: Froedtert Hospital, Mayo Clinic, Medical College of Wisconsin, The University of Texas Southwestern Medical Center

OpenAlex ID: A5026465769

Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial

2020 · Alain P. Algazi, Megan Othus, et al. · Nature Medicine · 120

Bootcamp during Neoadjuvant Chemotherapy for Breast Cancer: A Randomized Pilot Trial

2012 · Roshni Rao, Veronica Cruz, et al. · Breast Cancer Basic and Clinical Research · 58

Long-term prognosis of patients with clinical unstable angina pectoris without elevation of creatine kinase but with elevation of cardiac troponin i levels

2002 · Ronnier J Aviles, R.Scott Wright, et al. · The American Journal of Cardiology · 27

The role of coenzyme Q10 in the pathophysiology and therapy of experimental congestive heart failure in the dog

2000 · Amy K. Harker-Murray, A.Jamil Tajik, et al. · Journal of Cardiac Failure · 21

DC-HIL+ CD14+ HLA-DRno/low Cells Are a Potential Blood Marker and Therapeutic Target for Melanoma

2014 · Jake Turrentine, Jin-Sung Chung, et al. · Journal of Investigative Dermatology · 16

Clinical Impact and Accuracy of Shave Biopsy for Initial Diagnosis of Cutaneous Melanoma

2023 · Sherréa Jones, Valencia Henry, et al. · Journal of Surgical Research · 15

Unusual Lymphoma Manifestations

2004 · Michael A. Thompson, Amy Harker-Murray, et al. · Journal of Clinical Oncology · 13

Abstract CT013: SWOG S1320: Improved progression-free survival with continuous compared to intermittent dosing with dabrafenib and trametinib in patients with BRAF mutated melanoma

2020 · Alain Algazi, Megan Othus, et al. · Cancer Research · 5

Diffuse recurrent cutaneous melanoma of the scalp and neck successfully treated with volumetric modulated arc therapy and concurrent ipilimumab

2017 · Ryan K. Schmid, Amy Harker-Murray, et al. · Practical Radiation Oncology · 4

Xanthomatous Dermal Changes in a Patient With Locally Advanced Basal Cell Carcinoma Treated Using Vismodegib

2021 · Shane D. B. Smith, Callisia N. Clarke, et al. · American Journal of Dermatopathology · 1

Association of prior immune checkpoint blockade (ICB) with longer progression-free survival (PFS) in patients treated with intermittent versus continuous dabrafenib and trametinib: A post-hoc analysis of S1320.

2020 · Alain Patrick Algazi, Megan Othus, et al. · Journal of Clinical Oncology · 1

Clinical outcomes in patients with BRAFV600 mutant melanoma and undetectable circulating tumor DNA treated with dabrafenib and trametinib.

2020 · Alain Patrick Algazi, Megan Othus, et al. · Journal of Clinical Oncology

Works count: 12

Citation count: 281

H-index: 7

I10-index: 7